Pharma, Policy and politics 4/12/16 Pharma, Policy and politics 4/12/16 KaloBios bows to the price pressure Gods (I'm quoted) Read More Pharma, Policy and politics 4/1/16 Pharma, Policy and politics 4/1/16 Is pharma industry too meek on pricing? Read More Pharma, Research 3/16/16 Pharma, Research 3/16/16 Collaboration in pre-clinical and clinical development: interview with Dalvir Gill Read More Pharma, Policy and politics, Uncategorized 2/11/16 Pharma, Policy and politics, Uncategorized 2/11/16 Should Medicare negotiate drug prices? Probably not Read More Devices, Pharma, Policy and politics 1/3/16 Devices, Pharma, Policy and politics 1/3/16 How crazy is Ted Cruz's FDA reform proposal? Read More Pharma, Policy and politics, Technology 12/22/15 Pharma, Policy and politics, Technology 12/22/15 ICH endorses a faster, less expensive approach to cardiac safety testing Read More Economics, Entrepreneurs, Pharma, Policy and politics 12/17/15 Economics, Entrepreneurs, Pharma, Policy and politics 12/17/15 How Martin Shkreli is driving down drug prices Read More Amusements, Pharma 11/17/15 Amusements, Pharma 11/17/15 Invokana makes diabetes fun again! Read More Pharma, Policy and politics 11/10/15 Pharma, Policy and politics 11/10/15 Why Republicans will stumble on drug pricing policy Read More Patients, Pharma 10/14/15 Patients, Pharma 10/14/15 Let's stop calling flu vaccine for the elderly "High Dose" Read More Pharma, Policy and politics 9/30/15 Pharma, Policy and politics 9/30/15 Why drug price regulation should not be ruled out Read More Economics, Pharma 7/27/15 Economics, Pharma 7/27/15 Four reasons Praluent is not Sovaldi Read More Economics, Pharma, Policy and politics 7/20/15 Economics, Pharma, Policy and politics 7/20/15 Follow-on biologics: Another ho-hum assessment Read More Pharma, Policy and politics 7/9/15 Pharma, Policy and politics 7/9/15 The specialty drug pricing conundrum: Caps may raise costs, not lower them Read More International, Pharma 5/27/15 International, Pharma 5/27/15 Where the US lags Italy in healthcare Read More Culture, Economics, Pharma, Policy and politics 5/7/15 Culture, Economics, Pharma, Policy and politics 5/7/15 What's the difference between New York and Boston? Read More Pharma, Policy and politics 5/1/15 Pharma, Policy and politics 5/1/15 Big Vertex bonuses seem defensible to me Read More Culture, Economics, Pharma 4/7/15 Culture, Economics, Pharma 4/7/15 Cancer drugs: Why the high and rising prices? Read More Pharma 3/24/15 Pharma 3/24/15 Biosimilars are not generics Read More Economics, Medical travel/medical..., Patients, Pharma, Policy and politics 3/18/15 Economics, Medical travel/medical..., Patients, Pharma, Policy and politics 3/18/15 Sovaldi: a near-perfect example of price discrimination Read More Newer Posts Older Posts
Pharma, Policy and politics 4/12/16 Pharma, Policy and politics 4/12/16 KaloBios bows to the price pressure Gods (I'm quoted) Read More
Pharma, Policy and politics 4/1/16 Pharma, Policy and politics 4/1/16 Is pharma industry too meek on pricing? Read More
Pharma, Research 3/16/16 Pharma, Research 3/16/16 Collaboration in pre-clinical and clinical development: interview with Dalvir Gill Read More
Pharma, Policy and politics, Uncategorized 2/11/16 Pharma, Policy and politics, Uncategorized 2/11/16 Should Medicare negotiate drug prices? Probably not Read More
Devices, Pharma, Policy and politics 1/3/16 Devices, Pharma, Policy and politics 1/3/16 How crazy is Ted Cruz's FDA reform proposal? Read More
Pharma, Policy and politics, Technology 12/22/15 Pharma, Policy and politics, Technology 12/22/15 ICH endorses a faster, less expensive approach to cardiac safety testing Read More
Economics, Entrepreneurs, Pharma, Policy and politics 12/17/15 Economics, Entrepreneurs, Pharma, Policy and politics 12/17/15 How Martin Shkreli is driving down drug prices Read More
Pharma, Policy and politics 11/10/15 Pharma, Policy and politics 11/10/15 Why Republicans will stumble on drug pricing policy Read More
Patients, Pharma 10/14/15 Patients, Pharma 10/14/15 Let's stop calling flu vaccine for the elderly "High Dose" Read More
Pharma, Policy and politics 9/30/15 Pharma, Policy and politics 9/30/15 Why drug price regulation should not be ruled out Read More
Economics, Pharma, Policy and politics 7/20/15 Economics, Pharma, Policy and politics 7/20/15 Follow-on biologics: Another ho-hum assessment Read More
Pharma, Policy and politics 7/9/15 Pharma, Policy and politics 7/9/15 The specialty drug pricing conundrum: Caps may raise costs, not lower them Read More
International, Pharma 5/27/15 International, Pharma 5/27/15 Where the US lags Italy in healthcare Read More
Culture, Economics, Pharma, Policy and politics 5/7/15 Culture, Economics, Pharma, Policy and politics 5/7/15 What's the difference between New York and Boston? Read More
Pharma, Policy and politics 5/1/15 Pharma, Policy and politics 5/1/15 Big Vertex bonuses seem defensible to me Read More
Culture, Economics, Pharma 4/7/15 Culture, Economics, Pharma 4/7/15 Cancer drugs: Why the high and rising prices? Read More
Economics, Medical travel/medical..., Patients, Pharma, Policy and politics 3/18/15 Economics, Medical travel/medical..., Patients, Pharma, Policy and politics 3/18/15 Sovaldi: a near-perfect example of price discrimination Read More
